Deacylcynaropicrin Inhibits RANKL-Induced Osteoclastogenesis by Inhibiting NF-κB and MAPK and Promoting M2 Polarization of Macrophages

Eitemau Tebyg

• Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
  gan: Quan, Gui-Hua, et al.
  Cyhoeddwyd: (2015)
• Nepetin inhibits osteoclastogenesis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signalling pathway, and autophagy
  gan: Chu, Binxiang, et al.
  Cyhoeddwyd: (2020)
• Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
  gan: Yang, Xue, et al.
  Cyhoeddwyd: (2021)
• Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
  gan: Li, Xiucheng, et al.
  Cyhoeddwyd: (2021)
• Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
  gan: Guo, Wen, et al.
  Cyhoeddwyd: (2021)